Ribociclib and Letrozole Treatment in Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brian Slomovitz, MD
GOG
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, San Francisco
San Francisco, California, United States
- Uf Heath
Gainesville, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Northside Hospital
Atlanta, Georgia, United States
- Northshore University Healthsystem
Evanston, Illinois, United States
- Saint Vincent Hospital and Health Care Center, Inc.
Indianapolis, Indiana, United States
- St. Joseph Mercy Hospital Cancer Care Center
Ann Arbor, Michigan, United States
- Mayo Clinic - Rochester
Rochester, Minnesota, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- the Valley Hospital Inc.
Ridgewood, New Jersey, United States
- New Mexico Cancer Care Alliance/university of New Mexico Comprehensive Cancer Center
Albuquerque, New Mexico, United States
- Southwest Gynecologic Oncology Associates
Albuquerque, New Mexico, United States
- Miami Valley Hospital
Centerville, Ohio, United States
- the Ohio State Comprehensive Cancer Center
Columbus, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Oklahoma Cancer Care Specialists and Research Institute , Llc
Tulsa, Oklahoma, United States
- Western Pennsylvania Hospital/west Penn Hospital
Pittsburgh, Pennsylvania, United States
- Abington Memorial Hospital
Willow Grove, Pennsylvania, United States
- Women & Infants Hospital
Providence, Rhode Island, United States
- Parkland Health and Hospital System
Dallas, Texas, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Houston Methodist Hospital
Houston, Texas, United States
- Houston Methodist Willowbrook Hospital
Houston, Texas, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Memorial Hermann Texas Medical Center - Texas Medical Center
Houston, Texas, United States
- Houston Methodist Sugar Land Hospital
Sugar Land, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 May 2019
- Primary completion
- 23 Dec 2024
- Completion
- 31 Dec 2026
- Last update posted
- 23 Dec 2025
- Registered enrollment
- 51
- Registry id
- NCT03673124
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.